Aurobindo Pharma Ltd has announced that, pursuant to the applications received for conversion from some of the Bondholders, the Committee of the Board of Directors of the Company at its meeting held on July 27, 2010 has considered the request and allotted 14,54,625 Equity Shares of Rs. 5/- each for cash at a premium of 517.036 by conversion of Bonds worth USD 17,500,000 in terms of the offer document to the FCCB holders.
Consequent to the aforesaid allotment the paid up capital of the Company has gone up from 56480164 Equity Shares of Rs. 5/- each to 57934789 Equity Shares of Rs. 5/- each and the outstanding FCCBs for the issue of USD 60 Million Convertible Bonds due 2010 is now at USD 5.568 Million.
The stock was trading at Rs.945, up by Rs.12.55 or 1.35%. The stock hit an intraday high of Rs.946.90 and low of Rs.928.
The total traded quantity was 32181 compared to 2 week average of 20930.
|
Union Budget